Structural MRI Biomarkers of Mild Cognitive Impairment from Young Elders to Centenarians

被引:12
|
作者
Yang, Zixuan [1 ]
Wen, Wei [1 ]
Jiang, Jiyang [1 ]
Crawford, John D. [1 ]
Reppermund, Simone [1 ]
Levitan, Charlene [1 ,2 ]
Slavin, Melissa J. [3 ]
Kochan, Nicole A. [1 ,4 ]
Richmond, Robyn L. [5 ]
Brodaty, Henry [1 ,3 ]
Trollor, Julian N. [1 ,6 ]
Sachdev, Perminder S. [1 ,4 ]
机构
[1] Univ New S Wales, Sch Psychiat, Ctr Hlth Brain Ageing CHeBA, Sydney, NSW 2052, Australia
[2] Univ New S Wales, Prince Wales Clin Sch, Sydney, NSW 2052, Australia
[3] Univ New S Wales, Sch Psychiat, DCRC ABC, Sydney, NSW 2052, Australia
[4] Prince Wales Hosp, Neuropsychiat Inst, Randwick, NSW 2031, Australia
[5] Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW 2052, Australia
[6] Univ New S Wales, Sch Psychiat, Dept Dev Disabil Neuropsychiat, Sydney, NSW 2052, Australia
基金
英国医学研究理事会;
关键词
Advanced age; Alzheimer's disease; aMCI; brain atrophy; naMCI; structural MRI; VENTROLATERAL PREFRONTAL CORTEX; WHITE-MATTER HYPERINTENSITIES; CORPUS-CALLOSUM ATROPHY; SMALL VESSEL DISEASE; ALZHEIMERS-DISEASE; TEMPORAL-LOBE; DEFINED SUBTYPES; CEREBRAL-CORTEX; SYDNEY MEMORY; TISSUE LOSS;
D O I
10.2174/1567205013666151218150534
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Underpinnings of mild cognitive impairment (MCI) change with increasing age. We hypothesize that MRI signatures of mild cognitive impairment (MCI) would be different at a higher age compared to younger elders. Methods - 244 participants (71-103 years) from the Sydney Memory and Ageing Study and the Sydney Centenarian Study were categorized as amnestic MCI (aMCI), non-amnestic MCI (naMCI) or cognitively normal (CN). Brain "atrophy" and white matter hyper-intensities (WMHs) associated with MCI subtypes and age effects were examined by general linear models, controlling for confounding factors. Reduced logistic regressions were performed to determine structures that best discriminated aMCI from CN in individuals <85 and those >= 85 years. Results - aMCI was associated with smaller volumes of overall cortex, medial temporal structures, anterior corpus callosum, and select frontal and parietal regions compared to CN; such associations did not significantly change with age. Structures that best discriminated aMCI from CN differed however in the <85 and >= 85 age groups: cortex, putamen, parahippocampal, precuneus and superior frontal cortices in <85 years, and the hippocampus, pars triangularis and temporal pole in >= 85 years. Differences between naMCI and CN were small and non-significant in the sample. WMHs were not significantly associated with MCI subtypes. Conclusions - Structural MRI distinguishes aMCI, but not naMCI, from CN in elderly individuals. The structures that best distinguish aMCI from CN differ in those <85 from those >= 85, suggesting different neuropathological underpinnings of cognitive impairment in the very old.
引用
收藏
页码:256 / 267
页数:12
相关论文
共 50 条
  • [1] Structural and functional MRI in mild cognitive impairment
    Soininen, Hilkka
    Haemaelaeinen, Anne
    Pihlajamdki, Maija
    Niskanen, Eini
    Tervo, Susanna
    [J]. NEUROBIOLOGY OF AGING, 2008, 29 : S22 - S23
  • [2] Structural and Functional MRI in Mild Cognitive Impairment
    Pihlajamaki, Maija
    Jauhiainen, Anne M.
    Soininen, Hilkka
    [J]. CURRENT ALZHEIMER RESEARCH, 2009, 6 (02) : 179 - 185
  • [3] Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment
    de Leon, MJ
    DeSanti, S
    Zinkowski, R
    Mehta, PD
    Pratico, D
    Segal, S
    Rusinek, H
    Li, J
    Tsui, W
    Saint Louis, LA
    Clark, CM
    Tarshish, C
    Li, Y
    Lair, L
    Javier, E
    Rich, K
    Lesbre, P
    Mosconi, L
    Reisberg, B
    Sadowski, M
    DeBernadis, JF
    Kerkman, DJ
    Harnpel, H
    Wahlund, LO
    Davies, P
    [J]. NEUROBIOLOGY OF AGING, 2006, 27 (03) : 394 - 401
  • [4] Reliability and Validity of Food Frequency Questionnaire and Nutrient Biomarkers in Elders With and Without Mild Cognitive Impairment
    Bowman, Gene L.
    Shannon, Jackilen
    Ho, Emily
    Traber, Maret G.
    Frei, Balz
    Oken, Barry S.
    Kaye, Jeffery A.
    Quinn, Joseph F.
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2011, 25 (01): : 49 - 57
  • [5] Combination of Biomarkers: PET [18F]Flutemetamol Imaging and Structural MRI in Dementia and Mild Cognitive Impairment
    Thurfjell, Lennart
    Lotjonen, Jyrki
    Lundqvist, Roger
    Koikkalainen, Juha
    Soininen, Hilkka
    Waldemar, Gunhild
    Brooks, David J.
    Vandenberghe, Rik
    [J]. NEURODEGENERATIVE DISEASES, 2012, 10 (1-4) : 246 - 249
  • [6] CSF biomarkers for mild cognitive impairment
    Blennow, K
    [J]. JOURNAL OF INTERNAL MEDICINE, 2004, 256 (03) : 224 - 234
  • [7] Detecting conversion from mild cognitive impairment to Alzheimer's disease using FLAIR MRI biomarkers
    Crystal, Owen
    Maralani, Pejman J.
    Black, Sandra
    Fischer, Corinne
    Moody, Alan R.
    Khademi, April
    [J]. NEUROIMAGE-CLINICAL, 2023, 40
  • [8] Mild cognitive impairment classification using combined structural and diffusion imaging biomarkers
    Perez-Gonzalez, Jorge
    Jimenez-Angeles, Luis
    Rojas Saavedra, Karla
    Barbara Morales, Eduardo
    Medina-Banuelos, Veronica
    [J]. PHYSICS IN MEDICINE AND BIOLOGY, 2021, 66 (15):
  • [9] Use of Genetic Variation as Biomarkers for Mild Cognitive Impairment and Progression of Mild Cognitive Impairment to Dementia
    Reitz, Christiane
    Mayeux, Richard
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2010, 19 (01) : 229 - 251
  • [10] YOUNG MILD COGNITIVE IMPAIRMENT WITH MYOCLONUS
    Davies, R. R.
    Pohl, U.
    Fonseca, M-J
    Brown, K.
    de Silva, R. N.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2009, 80 (11):